Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Prescription Only: Use only as prescribed and under medical supervision
After this, a small cannula will be used to remove the liquid with the fat cells
View Program Important Notes on Choosing a Program Prescription requirement: All of these programs connect you with licensed prescribers who evaluate your eligibility before dispensing oral GLP-1s
Phase 1a: First-in-Human Single Ascending Dose Study (NCT02951806) Study Title: "Safety, Tolerability, and Pharmacokinetics of Single Doses of Cagrilintide in Healthy Subjects" Status: Completed Phase: Phase 1a Enrollment: 48 healthy volunteers Study Period: 2016-2017 Location: Single center (Denmark) Design: Randomized, double-blind, placebo-controlled, single ascending dose Dose Range: 0.03-10 mg SC Primary Endpoints: Safety, tolerability, PK parameters Population: Healthy male subjects, BMI 20-28 Key Results: Pharmacokinetics: Terminal half-life 5-7 days across dose range
Weight changes are determined by diet, exercise, metabolism, and hormonal balance, not by glutathione supplementation
US$ 23.84
US$ 28.84
US$ 27.96
US$ 21.53
US$ 20.14
:max_bytes(150000):strip_icc()/VWH-GettyImages-1807239973-944cddb21ce647c594217130457b8f00.jpg)
US$ 20.89
US$ 20.11
US$ 28.12
US$ 26.79
US$ 21.96
